RALY
RNA-binding protein Raly
Also known as: HNRPCL2, P542, RALY_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKM9
- Gene
- RALY
- Ensembl
- ENSG00000125970
- Chromosome
- 20
- Canonical length
- 306 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
This gene encodes a member of the heterogeneous nuclear ribonucleoprotein (hnRNP) gene family. This protein may play a role in pre-mRNA splicing and in embryonic development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
306 residues, UniProt reviewed canonical sequence.
>Q9UKM9|RALY
1 MSLKLQASNV TNKNDPKSIN SRVFIGNLNT ALVKKSDVET IFSKYGRVAG CSVHKGYAFV
61 QYSNERHARA AVLGENGRVL AGQTLDINMA GEPKPDRPKG LKRAASAIYS GYIFDYDYYR
121 DDFYDRLFDY RGRLSPVPVP RAVPVKRPRV TVPLVRRVKT NVPVKLFARS TAVTTSSAKI
181 KLKSSELQAI KTELTQIKSN IDALLSRLEQ IAAEQKANPD GKKKGDGGGA GGGGGGGGSG
241 GGGSGGGGGG GSSRPPAPQE NTTSEAGLPQ GEARTRDDGD EEGLLTHSEE ELEHSQDTDA
301 DDGALQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RALY can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 179 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 179 nTPM
- skeletal muscle: 168 nTPM
- blood vessel: 151 nTPM
- thymus: 151 nTPM
- heart muscle: 133 nTPM
- colon: 128 nTPM
Single-cell type
- neutrophils: 467 nCPM
- esophageal apical cells: 381 nCPM
- colonocytes: 378 nCPM
- enterocytes: 370 nCPM
- endometrial glandular cells: 357 nCPM
- extravillous trophoblasts: 339 nCPM
Immune cell
- eosinophil: 222 nTPM
- non-classical monocyte: 197 nTPM
- NK-cell: 187 nTPM
- neutrophil: 174 nTPM
- total PBMC: 165 nTPM
- memory CD8 T-cell: 150 nTPM
Brain region
- white matter: 133 nTPM
- medulla oblongata: 113 nTPM
- spinal cord: 105 nTPM
- pons: 101 nTPM
- basal ganglia: 101 nTPM
- cerebellum: 101 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0.14
- gnomAD missense Z
- 1.36
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 14% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol homeostasis
- mRNA splicing, via spliceosome
- negative regulation of transcription by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RALY in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RALY as an antibody target. Whether an autoantibody or antibody against RALY could matter depends on whether native RALY is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RALY is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RALY as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...